AA/Tunis
In Guadeloupe, Dengue fever has entered “the epidemic phase” with a rare serotype which could cause “a high number of cases”, according to an official press release released Thursday November 14 and relayed by French media.
Meeting during the day, the management committee chaired by the regional prefect recorded “the transition to the epidemic phase for dengue”, specifies this joint press release from the prefecture, the association of mayors of Guadeloupe and the Regional Agency of Health of Guadeloupe and the Northern Islands, specifies Franceinfo in its Overseas edition.
The authorities are launching “a call for the mobilization of all actors involved” in the fight “to try to minimize the impact of this disease” in the coming weeks, reports the same source.
This year, “a serotype of the dengue virus which has circulated little over the last twenty years”, DENV3, makes the authorities fear “risks of serious form” and “a high number of cases” if “resolute control actions or prevention are not implemented”, according to the press release.
Among 62 samples analyzed between the end of September and mid-October, “97% are DENV3”, according to the latest bulletin from Public Health France.
The seasonal threshold for clinical cases (80 weekly cases) is largely exceeded. At the end of October, it was estimated at 540 in community medicine, more than double that in September. At the hospital, Santé Publique France noted last month “on average 40 weekly visits to the emergency room for suspected dengue fever, compared to 25 in September”, underlines Franceinfo.
The joint statement from the authorities recalled that it was “essential” to fight against stagnant water which allows the larvae of the disease vector, the mosquito, to develop. These stagnant waters are often “located around or in homes” and may have been “fed by recent heavy rains”, underlines the press release.
Only part of the dispatches, which the Anadolu Agency broadcasts to its subscribers via the Internal Broadcasting System (HAS), is broadcast on the AA website, in summary form. Please contact us to subscribe.
